Global Lyophilized Injectable Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Lyophilized Injectable Market is presumed to reach the market size of nearly USD 13.73 BN by 2030 from USD 6.93 BN in 2022 with a CAGR of 8.92% under the study period 2023 - 2030.

Lyophilized injectables are freeze-dried medications that remain stable during transportation. Lyophilized injectables are created using the lyophilization process, which involves freezing and evaporating a solution under a vacuum to isolate a solid substance from a solvent. Lyophilized injectables are regarded as the most effective alternative to oral concrete dose forms. Bedridden individuals have greatly benefited from lyophilized injectables. Lyophilized injectables also provide maximum absorption and stability in patients suffering from various disorders since they have a longer shelf life than other doses.

MARKET DYNAMICS:

The vital factors driving the growth of the lyophilized injectables market are increased demand for contract research manufacturing services and rising pharmaceutical approvals. The increasing technological improvements in lyophilized injectable medications will likely fuel the growth of lyophilized injectable drugs. The increased regulatory approvals for lyophilized pharmaceuticals will likely stimulate demand for lyophilized injectable medications. The increase in the number of lyophilized medication product recalls and packaging types are projected to restrict the lyophilized injectable market. Factors related to the production of lyophilized vials for injectable products likely pose a challenge for these medications limiting the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of lyophilized injectable. The growth and trends of lyophilized injectable industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the lyophilized injectable market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Packaging

Single-Use Vials
Point-Of-Care Reconstitution
Specialty Packaging

By Delivery

Prefilled Diluent Syringes
Proprietary Reconstitution Devices
Single-Step Devices
Multi-Step Devices

By Indication

Autoimmune Diseases
Infectious Diseases
Metabolic Conditions
Others

By End User

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Lyophilized Injectable market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lyophilized injectable market include B. Braun Melsungen AG, Baxter International Inc., BD, Schott AG, Aristopharma Ltd., Vetter Pharma, Jubilant HollisterStier LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219936

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . LYOPHILIZED INJECTABLE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Packaging
- 3.7.2 Market Attractiveness Analysis By Delivery
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY PACKAGING

6.1 Overview by Packaging
6.2 Historical and Forecast Data
6.3 Analysis by Packaging
6.4 Single-use Vials Historic and Forecast Sales by Regions
6.5 Point-of-care Reconstitution Historic and Forecast Sales by Regions
6.6 Specialty Packaging Historic and Forecast Sales by Regions

7 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY DELIVERY

7.1 Overview by Delivery
7.2 Historical and Forecast Data
7.3 Analysis by Delivery
7.4 Prefilled Diluent Syringes Historic and Forecast Sales by Regions
7.5 Proprietary Reconstitution Devices Historic and Forecast Sales by Regions
7.6 Single-step Devices Historic and Forecast Sales by Regions
7.7 Multi-step Devices Historic and Forecast Sales by Regions

8 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY INDICATION

8.1 Overview by Indication
8.2 Historical and Forecast Data
8.3 Analysis by Indication
8.4 Autoimmune Diseases Historic and Forecast Sales by Regions
8.5 Infectious Diseases Historic and Forecast Sales by Regions
8.6 Metabolic Conditions Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY END USER

9.1 Overview by End User
9.2 Historical and Forecast Data
9.3 Analysis by End User
9.4 Hospitals Historic and Forecast Sales by Regions
9.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
9.6 Specialty Clinics Historic and Forecast Sales by Regions
9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE LYOPHILIZED INJECTABLE COMPANIES

11.1. Lyophilized Injectable Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF LYOPHILIZED INJECTABLE INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. B. Braun Melsungen AG
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Baxter International Inc.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. BD
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Schott AG
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Aristopharma Ltd.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Vetter Pharma
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Jubilant HollisterStier LLC
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies